In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits ...

If HHS' 340B rebate model pilot proceeds as planned, more than 2,700 U.S. hospitals will collectively be saddled with approximately $400 million ...

A recent report from the Congressional Budget Office found no evidence that savings from the 340B program are passed on to ...

In July, the Health Resources and Services Administration announced the availability of a voluntary 340B Rebate Model Pilot Program. The program is voluntary for drugmakers, but not for hospitals, ...

The 340B drug discount program incentivizes hospitals to purchase outpatient clinics and prescribe more and higher-cost drugs — behaviors that tend to increase costs for the federal government and ...

The 340B Drug Pricing Program allows certain medical facilities to buy drugs at a discount to support care for low-income patients. Rhode Island's new law, Chapter 288, prevents drug makers from ...

Congress is considering a new bill that, in theory, would boost low-income patients’ - especially Latinos’ - access to cheaper medicines. But in practice the legislation would achieve the exact ...

A bipartisan group of lawmakers has sent a letter to the Department of Health and Human Services, asking the agency to cancel an upcoming rebate pilot for drugs purchased by hospitals under the 340B ...

The 340B program, enacted by Congress in 1992, requires pharmaceutical companies to sell medications to rural hospitals at ...